Recent corrections
May 20, 2026
- Refreshed news.html with 5 new entries covering April 14, 2026 FDA action; CMS Wegovy Part D expansion (April 28); ESSENCE MASH interim (May 5); state pharmacy board investigations (May 8); Foundayo CV safety clearance (May 14).
- Updated llms.txt with current pricing snapshot and the post-April-2026-FDA-action regulatory posture.
- Added team pages: /team/dr-terra-walman.html, /team/dr-joseph-safer.html, /team/dr-adam-kennah.html, /team/.
- Added /methodology.html as standalone (the v3.0 rubric had previously lived only as a section in editorial-standards.html).
- Added /conflicts-of-interest.html with full disclosure of Dr. Kennah's NexLife dual role.
- Added /fact-checking-policy.html as standalone.
How to submit a correction
- Email semaglutideglpone@gmail.com with "Correction" in the subject line.
- Include the URL of the page in question.
- Quote the specific text you believe is inaccurate.
- State what you believe is correct.
- Provide a primary source (FDA document, peer-reviewed publication, state license record, etc.) supporting the correction.
What happens after you submit
- The Editor reviews the submission within 48 business hours.
- If the correction pertains to clinical content (mechanism, dosing, contraindications, drug interactions), it is escalated to the Clinical Accuracy Reviewer.
- If accepted: the article is updated with a brief corrections note (e.g., "Updated [date]: [what changed]"), and the entry is logged here.
- If declined: the submitter receives a brief explanation. Declined corrections are not logged.
What counts as "material"
Material corrections are: any change to a clinical claim (mechanism, dosing, contraindication, drug interaction, trial outcome); any change to a pricing claim; any change to a provider scoring decision; any change to a pharmacy or Medical Director claim; any change to an FDA regulatory claim. Material corrections always get a public log entry here.
Non-material updates are: typos, broken links, formatting cleanups, image alt-text fixes. These are made silently as part of normal editorial maintenance.
Re-scoring after a provider claim changes
When a reviewed provider's claim changes — new Medical Director named, new pharmacy partner added, pricing changed, new transparency document published — the provider may submit the change for re-scoring at the same editorial inbox. Re-scoring is conducted by the Lead Medical Researcher with Editor review and normally completes within 14 days. Score changes are logged here (this page) and reflected in llms.txt within the same week.
Historical corrections
Corrections logged prior to May 20, 2026 are preserved at the URL paths they were originally logged at (within editorial-standards.html). This page becomes the canonical corrections record going forward.